This webinar discussed recent developments and clinical evidence that have brought genomic biomarker testing to bear in advanced prostate cancer and the implementation of these tests in this setting. This session reviewed the different genomic and biomarker tests available for advanced prostate cancer, what they test for, and how to help patients decide whether to pursue these tests.